APOE and Alzheimer disease: Aβ deposition in the brains of normal controls and AD patients is higher in APOE4 carriers [198–202] and lower in APOE2 carriers compared with APOE3 carriers, and it appears earlier in healthy APOE4 carriers than in corresponding APOE4 non-carriers [203].